z-logo
Premium
Synthesis and in vitro evaluation of iodine labelled pyrazolo[1,5‐ a ]pyridines as highly selective dopamine D4 receptor ligands
Author(s) -
Prante O.,
Löber S.,
Hübner H.,
Gmeiner P.,
Kuwert T.
Publication year - 2001
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.508
Subject(s) - chemistry , radioligand , pyridine , in vitro , dopamine , receptor , dopamine receptor , radioligand assay , ligand (biochemistry) , chemical synthesis , stereochemistry , dopamine receptor d2 , biochemistry , medicinal chemistry , medicine
Two 131 I‐labelled radioligands, namely 3‐(4‐[ 131 I]iodophenylpiperazin‐1‐ylmethyl)‐pyrazolo[1,5‐ a ]pyridine and 3‐(4‐chlorophenylpiperazin‐1‐ylmethyl)‐7‐[ 131 I]iodopyrazolo[1,5‐ a ]pyridine, which are required for studies or binding of these ligands to the D4 receptor, have been synthesized in 80% and 32% radiochemical yields, respectively; the radiochemical purity in each case was >97%. For the second radioligand a kit preparation, based on iododestannylation followed by solid‐phase extraction, was possible. In vitro characterization using CHO‐cells expressing different dopamine receptor subtypes gave K i values of 3.1 and 2.6 nM. Both radioligands are highly selective for the D4 subtype as compared to other dopamine subtypes. Copyright © 2001 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom